Making the invisible visible-Phase dyssynchrony has potential as a new prognostic marker.
Making the invisible visible-Phase dyssynchrony has potential as a new prognostic marker.
复制标题
使不可见的相位不同步具有作为新的预后标记的潜力。
DOI:
10.1007/s12350-017-0929-5
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Slomka P.
中科院分区:
文献类型:
--
作者:
Nakajima K;Okuda K;Matsuo S;Slomka P.
Quantitative nuclear imaging analysis can enhance confidence in what is visible in the images. For example, defect scoring in myocardial perfusion studies can confirm the extent and severity of perfusion abnormalities, and left ventricular ejection fraction (LVEF) can confirm the severity of cardiac contractility so that the viewpoint is universally standardized. In contrast, phase dyssynchrony analysis renders what is invisible to the naked eye visible and thus provides a viewpoint that conventional functional parameters cannot produce. Although the methodology could be very attractive, phase dyssynchrony findings derived from patients with heart disease need to be appropriately understood. Phase analysis of the timing of ventricular contractions was initially introduced during the 1980s for gated blood-pool studies using 99mTc-red blood cells. 1 Some interesting results have been generated by visualizing sequences of contraction timing derived from pixelbased or region-based time-activity curves. Studies that have shown sequences of contraction timing include bundle branch block, 2 in which contraction is delayed in the electrically blocked ventricle, and pre-excitation syndrome, 3 in which contraction is early at the site of an accessory conduction pathway. Regional ventricular wall motion abnormalities are measured using the two parameters of phase and amplitude, which show hypokinesis and dyskinesis as a very low amplitude and a delayed phase, respectively. After the advent of gated myocardial perfusion single-photon emission computed tomography (SPECT), it has been used to evaluate regional dyssynchrony and to determine the need for cardiac resynchronization therapy (CRT). 4 Gated bloodpool studies use regional or pixel-based volume curves, whereas gated myocardial perfusion imaging (MPI) studies use wall thickening values or changes in counts. Current providers have recently included phase analysis in their software packages for quantitative analysis. 4-7 Information about phase in gated MPI studies is a new viewpoint that differs from conventional wall motion analysis, and the role of phase analysis in myocardial damage or primary and secondary cardiomyopathy has yet to be determined. In this issue of the Journal of Nuclear Cardiology, phase analysis was applied to patients with chronic kidney disease (CKD), and increased dyssynchrony was reportedly related to prognosis. 8 Before directly proceeding to clinical applications, we will review technologically confounding factors to understand the real value of phase analysis to clinical studies.